Observational Real-world Evaluation of Cost of Infections of RA Patients on Biologics.

Trial Profile

Observational Real-world Evaluation of Cost of Infections of RA Patients on Biologics.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2012

At a glance

  • Drugs Abatacept; Adalimumab; Etanercept; Infliximab
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 12 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Dec 2011 Planned End Date changed from 1 Dec 2011 to 1 Mar 2012 as reported by ClinicalTrials.gov.
    • 29 Aug 2011 Planned end date changed from Dec 2010 to Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top